Pathology of early hepatocellular carcinoma: Conventional and molecular diagnosis

Seminars in Liver Disease

Volumn 30, Issue 1, 2010, Pages 17-25

  Roskams, Tania ^a   Kojiro, Masamichi ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b KURUME UNIVERSITY   (Japan)

Author keywords

Dysplastic nodule; Glutamine synthetase; Glypican 3; Heat shock protein 70; Hepatocellular carcinoma; Nodule in nodule; Stromal invasion

Indexed keywords

GLUTAMATE AMMONIA LIGASE; GLYPICAN 3; HEAT SHOCK PROTEIN 70; MOLECULAR MARKER;

HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; PRIORITY JOURNAL; REVIEW;

BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTAMATE-AMMONIA LIGASE; GLYPICANS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77349103260     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0030-1247129     Document Type: Review

References (54)

1. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005 42 (5) 1208-1236
2. Bruix J, Sherman M. Diagnosis of small HCC. Gastroenterology 2005 129 (4) 1364
3. Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 2005 25 (2) 133-142
4. Party I W., International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995 22 (3) 983-993
5. International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 2009 49 (2) 658-664
6. Mion F, Grozel L, Boillot O, Paliard P, Berger F. Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology 1996 111 (6) 1587-1592
7. Terada T, Terasaki S, Nakanuma Y. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy. Cancer 1993 72 (5) 1551-1556
8. Hytiroglou P, Theise N D., Schwartz M, Mor E, Miller C, Thung S N. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature. Hepatology 1995 21 (3) 703-708
9. Libbrecht L, Bielen D, Verslype C et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002 8 (9) 749-761
10. Libbrecht L, Desmet V, Roskams T. Preneoplastic lesions in human hepatocarcinogenesis. Liver Int 2005 25 (1) 16-27
11. Arakawa M, Kage M, Sugihara S, Nakashima T, Suenaga M, Okuda K. Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases. Gastroenterology 1986 91 (1) 198-208
12. Anthony P P., Vogel C L., Barker L F. Liver cell dysplasia: a premalignant condition. J Clin Pathol 1973 26 (3) 217-223
13. Hytiroglou P. Morphological changes of early human hepatocarcinogenesis. Semin Liver Dis 2004 24 (1) 65-75
14. Terada T, Nakanuma Y. Survey of iron-accumulative macroregenerative nodules in cirrhotic livers. Hepatology 1989 10 (5) 851-854 (Pubitemid 19270173)
15. Kojiro M. Premalignant lesions of hepatocellular carcinoma: pathologic viewpoint. J Hepatobiliary Pancreat Surg 2000 7 (6) 535-541
16. Terada T, Nakanuma Y. Arterial elements and perisinusoidal cells in borderline hepatocellular nodules and small hepatocellular carcinomas. Histopathology 1995 27 (4) 333-339
17. Park Y N., Yang C P., Fernandez G J., Cubukcu O, Thung S N., Theise N D. Neoangiogenesis and sinusoidal capillarization in dysplastic nodules of the liver. Am J Surg Pathol 1998 22 (6) 656-662
18. Roncalli M, Roz E, Coggi G et al. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 1999 30 (5) 1174-1178
19. Maggioni M, Coggi G, Cassani B et al. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies. Hepatology 2000 32 (5) 942-946
20. Sun M, Eshleman J R., Ferrell L D. et al. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region. Hepatology 2001 33 (6) 1415-1424
21. Tornillo L, Carafa V, Sauter G et al. Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma. Lab Invest 2002 82 (5) 547-553
22. Plentz R, Park Y N., Lechel A et al. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology 2007 45 968-976
23. Borzio M, Fargion S, Borzio F et al. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 2003 39 (2) 208-214
24. Kojiro M. Pathology of Hepatocellular Carcinoma. Boston, MA Blackwell Publishing 2006
25. Matsui O, Takashima T, Kadoya M et al. Dynamic computed tomography during arterial portography: the most sensitive examination for small hepatocellular carcinomas. J Comput Assist Tomogr 1985 9 (1) 19-24
26. Kudo M, Tomita S, Tochio H et al. Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles. Radiology 1992 182 (1) 155-160
27. Bennett G L., Krinsky G A., Abitbol R J., Kim S Y., Theise N D., Teperman L W. Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol 2002 179 (1) 75-80
28. Krinsky G A., Lee V S., Theise N D. et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 2001 219 (2) 445-454
29. van den Bos I C., Hussain S M., Terkivatan T, Zondervan P E., de Man R A. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging. J Magn Reson Imaging 2006 24 (5) 1071-1080
30. Nakashima O, Sugihara S, Kage M, Kojiro M. Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins. Hepatology 1995 22 (1) 101-105
31. Nakano M, Saito A, Yamamoto M, Doi M, Takasaki K. Stromal and blood vessel wall invasion in well-differentiated hepatocellular carcinoma. Liver 1997 17 (1) 41-46
32. International Consensus Group for Hepatocellular NeoplasiaThe International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009 49 (2) 658-664
33. Dhillon A P., Colombari R, Savage K, Scheuer P J. An immunohistochemical study of the blood vessels within primary hepatocellular tumours. Liver 1992 12 (5) 311-318
34. Nakashima Y, Nakashima O, Hsia C C., Kojiro M, Tabor E. Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver 1999 19 (1) 12-18
35. Kimura H, Nakajima T, Kagawa K et al. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver 1998 18 (1) 14-19
36. Maeda T, Adachi E, Kajiyama K et al. CD34 expression in endothelial cells of small hepatocellular carcinoma: its correlation with tumour progression and angiographic findings. J Gastroenterol Hepatol 1995 10 (6) 650-654
37. Enzan H, Himeno H, Iwamura S et al. Alpha-smooth muscle actin-positive perisinusoidal stromal cells in human hepatocellular carcinoma. Hepatology 1994 19 (4) 895-903
38. Libbrecht L, Severi T, Cassiman D et al. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol 2006 30 (11) 1405-1411
39. Wang X Y., Degos F, Dubois S et al. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. Hum Pathol 2006 37 (11) 1435-1441
40. Capurro M, Wanless I R., Sherman M et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003 125 (1) 89-97
41. Midorikawa Y, Ishikawa S, Iwanari H et al. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer 2003 103 (4) 455-465
42. Nakatsura T, Yoshitake Y, Senju S et al. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Biophys Res Commun 2003 306 (1) 16-25
43. Sung Y K., Hwang S Y., Park M K. et al. Glypican-3 is overexpressed in human hepatocellular carcinoma. Cancer Sci 2003 94 (3) 259-262
44. Moriguchi H, Sato C. The values and limitations of glypican-3 as a novel tumor marker for hepatocellular carcinoma from clinical and economic viewpoints. Gastroenterology 2004 127 (2) 679-680
45. Kandil D, Leiman G, Allegretta M et al. Glypican-3 immunocytochemistry in liver fine-needle aspirates: a novel stain to assist in the differentiation of benign and malignant liver lesions. Cancer 2007 111 (5) 316-322
46. Garrido C, Gurbuxani S, Ravagnan L, Kroemer G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 2001 286 (3) 433-442
47. Helmbrecht K, Zeise E, Rensing L. Chaperones in cell cycle regulation and mitogenic signal transduction: a review. Cell Prolif 2000 33 (6) 341-365
48. Chuma M, Sakamoto M, Yamazaki K et al. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 2003 37 (1) 198-207
49. Di Tommaso L, Franchi G, Park Y N. et al. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 2007 45 (3) 725-734
50. Moorman A FM, De Boer P A., Das A T., Labruyre W T., Charles R, Lamers W H. Expression patterns of mRNAs for ammonia-metabolizing enzymes in the developing rat: the ontogenesis of hepatocyte heterogeneity. Histochem J 1990 22 (9) 457-468
51. Moorman A F., Vermeulen J L., Charles R, Lamers W H. Localization of ammonia-metabolizing enzymes in human liver: ontogenesis of heterogeneity. Hepatology 1989 9 (3) 367-372
52. Christa L, Simon M T., Flinois J P., Gebhardt R, Brechot C, Lasserre C. Overexpression of glutamine synthetase in human primary liver cancer. Gastroenterology 1994 106 (5) 1312-1320
53. Zucman-Rossi J, Benhamouche S, Godard C et al. Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas. Oncogene 2007 26 (5) 774-780
54. Osada T, Sakamoto M, Nagawa H et al. Acquisition of glutamine synthetase expression in human hepatocarcinogenesis: relation to disease recurrence and possible regulation by ubiquitin-dependent proteolysis. Cancer 1999 85 (4) 819-831